Drug Free Solution (DSOL) Financial Statements

9 Followers

Drug Free Solution Financial Overview

Drug Free Solution's market cap is currently $113.36K. The company's EPS TTM is $; its P/E ratio is -16.94; Drug Free Solution is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	May 20	May 19
Income Statement
Total Revenue	$ 805.00	$ 1.77K
Gross Profit	$ 805.00	$ -9.23K
Operating Income	$ -1.41M	$ -1.45M
EBITDA	$ -1.39M	$ -1.44M
Net Income	$ -1.41M	$ -1.45M
Balance Sheet
Cash & Short-Term Investments	$ 12.50K	$ 2.53K
Total Assets	$ 52.51K	$ 18.05K
Total Debt	$ 0.00	$ 0.00
Net Debt	$ -12.50K	$ -2.53K
Total Liabilities	$ 333.30K	$ 256.30K
Stockholders' Equity	$ -280.79K	$ -238.25K
Cash Flow
Free Cash Flow	$ -419.73K	$ -420.30K
Operating Cash Flow	$ -382.90K	$ -401.50K
Investing Cash Flow	$ -36.83K	$ -18.80K
Financing Cash Flow	$ 429.71K	$ 422.83K

Currency in USD

Drug Free Solution Earnings and Revenue History

Income Statement >

Drug Free Solution Debt to Assets

Balance Sheet >

Drug Free Solution Cash Flow

Cash Flow >

Drug Free Solution Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >